Literature DB >> 7687152

Virulence characteristics of Escherichia coli in nosocomial urinary tract infection.

R Ikäheimo1, A Siitonen, U Kärkkäinen, P H Mäkelä.   

Abstract

We examined 148 strains of Escherichia coli isolated from the urine from patients with nosocomial urinary tract infection (UTI). The prevalence of P fimbriation was only 11.5%. Of the strains, 17.6% expressed non-P M(R) adhesins (defined as strains expressing mannose-resistant but not P-specific hemagglutination); 33.1% produced hemolysin, and 15.2% expressed type 1C fimbriae. O6 was the most common group of O antigens (12.2%), closely followed by O75 (9.5%); both of these groups are relatively uncommon (4.5% and 1%, respectively) in fecal strains isolated from healthy adults. Of the strains with O6 and O75 antigens, 78.8% and 79% produced hemolysin, but of all other strains causing UTI, only 21% produced hemolysin. Of the strains with O6 antigens, 61% expressed non-P M(R) adhesins, but only 12% of all other strains causing UTI expressed non-P M(R) adhesins. There were no significant differences in the prevalence of virulence properties between strains isolated from patients with or without an underlying medical illness or between strains causing different clinical categories of UTI. We conclude that the prevalence of bacterial virulence factors is low among patients with nosocomial UTI.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687152     DOI: 10.1093/clind/16.6.785

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  Escherichia coli serotype O15:K52:H1 as a uropathogenic clone.

Authors:  G Prats; F Navarro; B Mirelis; D Dalmau; N Margall; P Coll; A Stell; J R Johnson
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Oral administration of a certain strain of live Escherichia coli for intestinal disorders? Artificial contamination and manipulation of the digestive tract--our poor GIT!

Authors: 
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

3.  Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism.

Authors:  T G Gleason; C W Houlgrave; A K May; T D Crabtree; R G Sawyer; W Denham; J G Norman; T L Pruett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

4.  Virulence factors and O groups of Escherichia coli isolates from patients with acute pyelonephritis, cystitis and asymptomatic bacteriuria.

Authors:  M Blanco; J E Blanco; M P Alonso; J Blanco
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

5.  Phenotypic study of virulence factors in Escherichia coli isolated from antenatal cases, catheterized patients, and faecal flora.

Authors:  Shruthi N; Ravi Kumar; Ravish Kumar
Journal:  J Clin Diagn Res       Date:  2012-10-26

Review 6.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

7.  Ribotyping as an epidemiologic tool for Escherichia coli.

Authors:  E Tarkka; H Ahman; A Siitonen
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

Review 8.  Urinary tract infection in the neurogenic bladder.

Authors:  Humberto R Vigil; Duane R Hickling
Journal:  Transl Androl Urol       Date:  2016-02

9.  A Biomimetic Porcine Urothelial Model for Assessing Escherichia coli Pathogenicity.

Authors:  Luka Predojević; Darja Keše; Darja Žgur Bertok; Taja Železnik Ramuta; Peter Veranič; Mateja Erdani Kreft; Marjanca Starčič Erjavec
Journal:  Microorganisms       Date:  2022-04-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.